Shamini Selvarajah
PhD, FACMGG, FCCMG
Dr Selvarajah obtained her PhD at the University of Toronto, before heading to Boston for a post-doctoral fellowship with the Dana-Farber Cancer Institute and an ABMGG clinical laboratory fellowship with the Harvard Medical School Genetics Training Program.
Upon returning to Toronto, she completed a second laboratory fellowship in Clinical Molecular Genetics at McMaster University while working as a Cytogenomicist at Trillium Health Partners.
She is currently a clinical molecular geneticist in the Division of Clinical Laboratory Genetics at the University Health Network.
Her academic interests are focused on genitourinary cancer genomics and biomarker development through the application of high throughput technologies.
She is an Assistant Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, and has been actively involved in teaching undergraduates and medical students in the area of cancer genetics.
Research Synopsis
My research interests are focused on the identification of molecular signatures associated with disease progression in genitourinary malignancies, particularly bladder and prostate cancer.
The dissection of clinically relevant genomic alterations may identify markers with prognostic and/or predictive potential, which can in turn facilitate risk stratification and enable therapeutic management.